Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

Related Articles by Review for PubMed (Select 18755864)

1.

Therapeutic benefit of treatment with anti-thymocyte globulin and latent TGF-beta1 in the MRL/lpr lupus mouse model.

Kaplan J, Woodworth L, Smith K, Coco J, Vitsky A, McPherson J.

Lupus. 2008 Sep;17(9):822-31. doi: 10.1177/0961203308091635.

PMID:
18755864
2.

Regulatory T cells in systemic lupus erythematosus: past, present and future.

Horwitz DA.

Arthritis Res Ther. 2008;10(6):227. doi: 10.1186/ar2511. Epub 2008 Nov 14. Review.

3.

Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship.

Wipff PJ, Hinz B.

Eur J Cell Biol. 2008 Sep;87(8-9):601-15. doi: 10.1016/j.ejcb.2008.01.012. Epub 2008 Mar 14. Review.

PMID:
18342983
4.

Chemokine blockade for lupus model mice.

Hasegawa H.

Front Biosci. 2008 Jan 1;13:2900-8. Review.

PMID:
17981762
5.
6.

TGF-beta as a promising option in the treatment of multiple sclerosis.

Mirshafiey A, Mohsenzadegan M.

Neuropharmacology. 2009 May-Jun;56(6-7):929-36. doi: 10.1016/j.neuropharm.2009.02.007. Epub 2009 Mar 11. Review.

PMID:
19285095
7.

B cell depletion in systemic lupus erythematosus.

Leandro MJ, Ehrenstein MR.

Clin Med. 2007 Jan-Feb;7(1):57-9. Review. No abstract available.

PMID:
17348577
8.

Childhood hermolytic uremic syndrome associated with systemic lupus erythematosus.

Wu CY, Su YT, Wang JS, Chiou YH.

Lupus. 2007;16(12):1006-10. Review. No abstract available.

PMID:
18042599
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk